216
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Development of tolerance upon repeated administration with the GABAB receptor positive allosteric modulator, COR659, on alcohol drinking in rodents

, , , , , , , , , , & show all
Pages 662-672 | Received 03 May 2022, Accepted 21 Aug 2022, Published online: 12 Sep 2022
 

ABSTRACT

Background: Recent work has demonstrated that acute administration of the novel positive allosteric modulator of the GABAB receptor, COR659, reduces several alcohol-related behaviors in rodents.

Objective: To assess whether COR659 continues to lessen alcohol intake after repeated administration, a fundamental feature of drugs with therapeutic potential.

Methods: Male C57BL/6J mice (n = 40) were exposed to daily 2-hour drinking sessions (20% (v/v) alcohol) under the 1-bottle “drinking in the dark” protocol and male Sardinian alcohol-preferring rats (n = 40) were exposed to daily 1-hour drinking sessions under the 2-bottle “alcohol (10%, v/v) vs water” choice regimen. COR659 (0, 10, 20, and 40 mg/kg in the mouse experiment; 0, 5, 10, and 20 mg/kg in the rat experiment) was administered intraperitoneally before 7 consecutive drinking sessions.

Results: Alcohol intake in vehicle-treated mice and rats averaged 2.5–3.0 and 1.5–1.6 g/kg/session, respectively, indicative of high basal levels. In both experiments, treatment with COR659 resulted in an initial, dose-related suppression of alcohol intake (up to 70–80% compared to vehicle treatment; P < .0005 and P < .0001 in mouse and rat experiments, respectively). The magnitude of the reducing effect of COR659 on alcohol drinking diminished progressively, until vanishing over the subsequent 2–4 drinking sessions.

Conclusion: COR659 effectively reduced alcohol intake in two different rodent models of excessive alcohol drinking. However, tolerance to the anti-alcohol effects of COR659 developed rapidly. If theoretically transposed to humans, these data would represent a possible limitation to the clinical use of COR659.

Acknowledgements

The authors are grateful to Mrs. Carla Acciaro for breeding and care of sP rats.

Disclosure statement

Mauro A.M. Carai, Giancarlo Colombo, Federico Corelli, Gian Luigi Gessa, Claudia Mugnaini, and Paola Maccioni are inventors on patent application no. 102016000030477 entitled “Use of 2-(acylamino)thiophene derivatives for the treatment of food dependence.”

Additional information

Funding

This work has been partially supported by grant no. [EA 17 14] from European Foundation for Alcohol Research (ERAB) and NIH Grants [AA028982, AA021667]. Authors from the University of Siena thank MIUR Progetto Dipartimenti di Eccellenza 2018-2022 for partial support.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 987.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.